Retrospective cohort of 24 women >65 with OTA 13.C2/13.C3 distal humerus fractures comparing ORIF (n=12) vs. primary TEA (n=12), using the Mayo Elbow Performance score and need for revision surgery as primary outcomes at minimum 2-year follow-up.
When you see a complex intraarticular distal humerus fracture (OTA 13.C2/C3) in a woman over 65 with osteoporosis, rheumatoid arthritis, or systemic steroid use, think primary TEA — this paper showed a 25% ORIF failure rate in exactly that population, while TEA yielded 11/12 excellent results with minimal rehabilitation burden.
In patients with good bone stock and no major comorbidities, experienced-surgeon ORIF remains a viable first choice.
Retrospective cohort of 24 women >65 with OTA 13.C2/13.C3 distal humerus fractures comparing ORIF (n=12) vs. primary TEA (n=12), using the Mayo Elbow Performance score and need for revision surgery as primary outcomes at minimum 2-year follow-up.
When you see a complex intraarticular distal humerus fracture (OTA 13.C2/C3) in a woman over 65 with osteoporosis, rheumatoid arthritis, or systemic steroid use, think primary TEA — this paper showed a 25% ORIF failure rate in exactly that population, while TEA yielded 11/12 excellent results with minimal rehabilitation burden.
In patients with good bone stock and no major comorbidities, experienced-surgeon ORIF remains a viable first choice.